CA
NZ
UK
AU
IND
US
The company makes differentiated analog semiconductors for data center, mobile, automotive and imaging customers, and operates fabs in Israel, the United States, Japan and Italy.Gross Profitclimbed 92% to $179 million, and operating profit reached $127 million, 2.5 times the year-earlier figure.
Net income was $26 million, or $0.02 per diluted share, versus a loss of $1.923 billion a year earlier, when the company booked a $1.913 billion impairment. Adjusted net income was $1 million, or roughly zero per share, compared with $62 million, or $0.06. …
The company develops treatments for rare kidney and metabolic diseases. FILSPARI sales were $200.2 million versus $90.9 million, while tiopronin products slipped to $20.0 million from $22.3 million. Management said it was the first quarter with net product sales above $200 million.
UDR is a multifamily real estateInvestmenttrust that owns, buys, sells, develops and redevelops apartment communities in targeted U.S. markets. It held an ownership position in 60,617 apartment homes as of Sep 30, 2026. TotalRevenuefor the quarter was $428.1 million, down 0.9% from $431.9 million, …
Net income was $3.1 million versus $9.3 million a year earlier. After preferred dividends of $5.3 million, the company reported a net loss attributable to common shareholders of $2.1 million, or $0.02 per share, versus income of $4.2 million, or $0.05 per share.
Adjusted net loss, which excludesTransaction Coststied to recent acquisitions, was $0.7 million, or $0.04 per share, a decline of $1.1 million from last year.Operating Incomeslipped to $6.8 million from $7.0 million, while net interest expense rose to $11.0 million from $8.9 million on higher …
Upwork runs an online marketplace that connects businesses with independent professionals, and it also offers an enterprise platform called Lifted. Total operating expenses fell to $106.7 million from $126.1 million, withResearch and Developmentdropping to $34.9 million from $47.5 million. Management said the quarter's revenue …
The gain came from program increases in aerospace and modernization, plus a $128.9 million increase from discrete activities supporting a national security mission. Revenue from U.S. programs rose by $209.4 million, or 31% by management's account, while Asia Pacific revenue rose 8%. Middle East …
Adjusted EBITDA climbed to $151 million from $97 million. Revenues excluding reimbursable items rose to $556 million from $502 million, mainly because three drillships started new contracts during the second and third quarters after idle periods, and another began work at a higher day …
The company attributed the growth mainly to its cystic fibrosis medicines, including new patient starts on ALYFTREK and higher realized net prices, along with contributions from CASGEVY, JOURNAVX and PALSONIFY. Reimbursement for ALYFTREK now covers 32 countries after seven were added in the quarter.
Please wait processing your request...